Drug Shortage Report for PHENYTOIN SODIUM INJECTION USP
Report ID | 130358 |
Drug Identification Number | 02431378 |
Brand name | PHENYTOIN SODIUM INJECTION, USP |
Common or Proper name | PHENYTOIN SODIUM INJECTION, USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PHENYTOIN SODIUM |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 25 VIALS 2 ML |
ATC code | N03AB |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-12-17 |
Estimated end date | 2020-12-24 |
Actual end date | 2020-12-24 |
Shortage status | Resolved |
Updated date | 2020-12-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-12-17 | English | Compare |
v2 | 2020-12-17 | French | Compare |
v3 | 2020-12-18 | English | Compare |
v4 | 2020-12-24 | English | Compare |
v5 | 2020-12-24 | English | Compare |
v6 | 2020-12-24 | French | Compare |
v7 | 2020-12-25 | English | Compare |
Showing 1 to 7 of 7